American Oriental Bioengineering to Report Third Quarter 2009 Financial Results on November 16, 2009
More News related to AOB
- China Business Knowledge Launches "China Prospects Forum" -- Dec. 9, 2009, NYC
- After-Hours Movers 11/16: ZOOM, SPRD, LFT, SINA Higher; PSUN, ADG, SIVB, AOB, SII, TGP Lower
- American Oriental Bioengineering (AOB) Posts Q3 EPS of $0.13, Misses by 4c
- American Oriental Bioengineering Reports Third Quarter 2009 Financial Results
- Trading Radar for 11/16: Lowe's (LOW), Pacific Sunwear (PSUN), Assured Guaranty (AGO), Franklin Covey (FC) Report
More News related to Press Releases
- Dubai Gov't Issues Update on Dubai World's Debt Obligations
- Dubai Debt Talks Boost Stocks
- Dubai World says total debt affected is about $26B
- Tiger Woods won't play in his own golf tournament this week
- Chelsea Clinton Engaged To Former Goldman Sachs Banker Marc Mezvinsky
NEW YORK, Nov. 9 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that it plans to release third quarter 2009 financial results on Monday, November 16, 2009, after the market closes.
The Company will hold a conference call at 8:00 am ET on Tuesday, November 17, 2009 to discuss third quarter 2009 results. Listeners may access the call by dialing 1-866-770-7051 or 1-617-213-8064 for international callers, access code: 89648638. A webcast will also be available through AOB's website at http://www.bioaobo.com .
A replay of the call will be available through November 24, 2009. Listeners may access the replay by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 58148119.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.
SOURCE American Oriental Bioengineering, Inc.
Related Categories
Press ReleasesStocks Mentioned
+0.12Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
